CSL Limited
CSLLYOTCHealthcare● Active
$17.12
+$0.00(+0.00%)
Market Cap$66.3B
P/E Ratio—
52W High$44.855
52W Low$16.29
CSL Limited (CSLLY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CSLLY · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 8, 2026EPS Actual
$0.06
Revenue
$8.30B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 8, 2026
After Market Close
CSLLY reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 8, 2026 | — | $0.06 | — | $8.30B | — | — |
| ◌ Q3 FY2025 | Aug 19, 2025 | — | — | — | — | — | — |
| — Q1 FY2025 | Feb 11, 2025 | — | $0.52 | — | $8.21B | — | — |
| — Q4 FY2024 | Oct 30, 2024 | — | $2.03 | — | $4.16B | — | — |
| — Q3 FY2024 | Aug 13, 2024 | — | $0.19 | — | $6.75B | — | — |
| — Q2 FY2024 | Apr 11, 2024 | — | $0.51 | — | $8.36B | — | — |
| — Q2 FY2024 | Apr 11, 2024 | — | $0.76 | — | $3.36B | — | — |
| — Q1 FY2024 | Feb 13, 2024 | — | $1.95 | — | $4.01B | — | — |
Q1 FY2026
Feb 8, 2026
EPS Actual
$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
$8.30B
Q3 FY2025
Aug 19, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Feb 11, 2025
EPS Actual
$0.52
EPS Est.
—
EPS Surpr.
—
Revenue
$8.21B
Q4 FY2024
Oct 30, 2024
EPS Actual
$2.03
EPS Est.
—
EPS Surpr.
—
Revenue
$4.16B
Q3 FY2024
Aug 13, 2024
EPS Actual
$0.19
EPS Est.
—
EPS Surpr.
—
Revenue
$6.75B
Q2 FY2024
Apr 11, 2024
EPS Actual
$0.51
EPS Est.
—
EPS Surpr.
—
Revenue
$8.36B
Q2 FY2024
Apr 11, 2024
EPS Actual
$0.76
EPS Est.
—
EPS Surpr.
—
Revenue
$3.36B
Q1 FY2024
Feb 13, 2024
EPS Actual
$1.95
EPS Est.
—
EPS Surpr.
—
Revenue
$4.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 8, 2026 | — | $32.11 | $32.23 | +0.37% |
| — Q1 FY2025 | Feb 11, 2025 | — | $42.30 | $40.48 | -4.30% |
| — Q4 FY2024 | Oct 30, 2024 | — | $47.93 | $47.48 | -0.94% |
| — Q3 FY2024 | Aug 13, 2024 | — | $50.99 | $49.32 | -3.28% |
| — Q2 FY2024 | Apr 11, 2024 | — | $46.00 | $45.75 | -0.54% |
| — Q2 FY2024 | Apr 11, 2024 | — | $46.00 | $45.75 | -0.54% |
| — Q1 FY2024 | Feb 13, 2024 | — | $47.36 | $44.96 | -5.07% |
| — Q2 FY2023 | Jun 30, 2023 | — | $45.89 | $46.13 | +0.52% |
Q1 FY2026+0.37%
Report Date
Feb 8, 2026
EPS Beat/Miss
—
Price Before
$32.11
Price After
$32.23
Q1 FY2025-4.30%
Report Date
Feb 11, 2025
EPS Beat/Miss
—
Price Before
$42.30
Price After
$40.48
Q4 FY2024-0.94%
Report Date
Oct 30, 2024
EPS Beat/Miss
—
Price Before
$47.93
Price After
$47.48
Q3 FY2024-3.28%
Report Date
Aug 13, 2024
EPS Beat/Miss
—
Price Before
$50.99
Price After
$49.32
Q2 FY2024-0.54%
Report Date
Apr 11, 2024
EPS Beat/Miss
—
Price Before
$46.00
Price After
$45.75
Q2 FY2024-0.54%
Report Date
Apr 11, 2024
EPS Beat/Miss
—
Price Before
$46.00
Price After
$45.75
Q1 FY2024-5.07%
Report Date
Feb 13, 2024
EPS Beat/Miss
—
Price Before
$47.36
Price After
$44.96
Q2 FY2023+0.52%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$45.89
Price After
$46.13
Beat Rate0 / 8 quarters
Largest Move-5.07% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CSLLY ends December
CSL Limited (CSLLY) most recently reported earnings on February 8, 2026 for Q1 FY2026, posting EPS of $0.06 (in line with the analyst consensus of —). The next CSLLY earnings date is expected around September 1, 2026.
Each quarter, investors track CSLLY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CSLLY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CSLLY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CSLLY earnings · 4 questionsCSL Limited's next earnings report is expected around September 1, 2026. CSLLY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CSLLY historically reports after market close (AMC).
CSLLY earnings datewhen is CSLLY earningsCSLLY next earnings datewhen does CSLLY report earningsCSLLY earnings calendar
▸ Source: FMP · CSL Limited SEC filings · US GAAP · CSL Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026